Global DNA And Gene Chip Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

The DNA And Gene Chip Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the DNA And Gene Chip Market Size Expected to Be by 2034?
The size of the DNA and gene chip market has witnessed significant expansion in the recent past. The market size is projected to surge from $8.19 billion in 2024 to $9.27 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.1%. The development seen in the historical period is due to progress in genomic studies, the emergence of personalized medicine, achievements reached in the human genome project, advancements in drug discovery and development, as well as the identification of disease biomarkers.

Expectations indicate a swift expansion in the market size of DNA and gene chips in the forthcoming years. With a compound annual growth rate (CAGR) of 13.4%, the market is predicted to reach $15.35 billion by 2029. The growth in this period can be linked to progress in precision medicine, development in biomarker discovery, expansion in personalized therapeutics, its utilization in cancer research, and increased research funding. Other pivotal trends within this forecast period encompass technological evolution, product renovation, regulatory framework and compliance, focus on unique diseases, and a constant decrease in expenses.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8205

What Are the Emerging Segments Within the DNA And Gene Chip Market?
The DNA and gene chip market covered in this report is segmented -

1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

Subsegments:
1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays
2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays
3) By Other Types: Single-Cell RNA Sequencing Chips, SNP (Single Nucleotide Polymorphism) Chips, Whole Genome Amplification Chips

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

What Long-Term Drivers Are Shaping DNA And Gene Chip Market Trends?
The DNA and gene market expansion is significantly influenced by the increasing necessity for early cancer detection. Cancer is an expansive category of diseases that could originate from virtually any organ or tissue within the body, when abnormal cells grow beyond control, override the confines of normal cells, invade nearby organs, and metastasize to other body parts. DNA and gene chips play a crucial role in evaluating gene expression patterns, understanding the genetic and epigenetic terrain, and assessing genomic regulatory elements attached to cancer transcription factors in cancerous cells. For example, in 2022, the American Cancer Society, a community-based, voluntary health organization from the US, forecasts a rough estimate of 1.9 million new cancer diagnoses and approximately 609,360 cancer-related fatalities in the United States. Consequently, the escalating demand for early cancer detection is propelling the growth of the DNA and gene chip market.

Who Are the Top Competitors in Key DNA And Gene Chip Market Segments?
Major companies operating in the DNA and gene chip market are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Cepheid, Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences

What DNA And Gene Chip Market Trends Are Gaining Traction Across Different Segments?
The increasing trend in the DNA and gene chip market is strategic alliances and cooperation. Firms in this field seek such associations to bolster their market stance. For example, in June 2022, a four-year strategic collaboration was inked between Avesthagen Limited, a Indian system biology platform corporation, and Wipro Limited, an IT firm in India. The partnership aims to carry out a project titled Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA, dedicated to genomics sequencing services associated with lung cancer. Additionally, in May 2022, a US-based provider of analytical instruments, Thermo Fisher Scientific, teamed up with Qatar Genome Program (QGP), part of Qatar Foundation (QF), to create a custom Axiom genotyping array for pan-Arab populations, leveraging whole genome sequencing data from 19 Arab nations. With 800,000 variants, this array aims to enhance research in genomics, with a special focus on conditions such as diabetes, cardiovascular diseases, autism, and cancer. This partnership aligns with Qatar's national vision for better population health and the evolution of precision medicine for people of Arab descent worldwide. Thermo Fisher's Axiom microarray technology paves the way for quicker precision medicine initiatives.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Which Regions Are Becoming Hubs for DNA And Gene Chip Market Innovation?
North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the DNA And Gene Chip Market?
2. What is the CAGR expected in the DNA And Gene Chip Market?
3. What Are the Key Innovations Transforming the DNA And Gene Chip Industry?
4. Which Region Is Leading the DNA And Gene Chip Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.